Skip to content

Repligen RGEN EV / sales

EV / sales at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
5.1×-0.9×
Danaher logo
DanaherDHR
-0.8×
Maravai LifeSciences Holdings, Inc. logo
Maravai LifeSciences Holdings, Inc.MRVI
2.5×+1.1×
Agilent Technologies logo
Agilent TechnologiesA
4.8×-0.2×
TEC
Bio-TechneTECH
6.8×-1.1×
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
3.1×+0.1×

Other financials

Income statement

See full
Revenue$194.3M+14.8%
Gross profit$108.3M+18.5%
Operating income$15.9M+142%
Net income$8.3M+42.9%
EPS (diluted)$0.15+50.0%

Balance sheet

See full
Cash & equivalents$582.7M-16.4%
Total debt$687.6M+346%
Total equity$2.1B+6.0%
Total assets$2.9B+2.8%

Cash flow

See full
Operating cash flow$28.3M+88.6%
CapEx$4.7M+32.2%
Free cash flow$23.6M+106%

Valuation

See full
Market cap$8.19B+22.7%
Enterprise value$8.3B+35.3%
P/E159.4×
P/S11.2×-0.1×

Profitability

See full
Gross margin49.5%+2.7pp
Operating margin1.5%-14.0pp
Net margin17.1%-3.7pp
FCF margin21.2%+6.1pp

Returns & leverage

See full
Return on equity2.5%+1.9pp
Debt / equity0.3×+0.2×
Current ratio9.2×+2.4×

Where this comes from

Calculated from Repligen’s reported figures.

Based on the most recent quarter.

The official record: Repligen’s 10-Q, filed November 18, 2024, on SEC EDGAR. View the filing →

Ask your AI about Repligen's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Repligen's EV / sales?
Repligen (RGEN) reported EV / sales of 12.2× in Q3 2024.
How has Repligen's EV / sales changed year-over-year?
Repligen's EV / sales decreased by 2.7% year-over-year, from 12.5× to 12.2×.
What is the long-term trend for Repligen's EV / sales?
Over 3 years (2020 to 2023), Repligen's EV / sales has grown at a -18.8% compound annual growth rate (CAGR), from 27.1× to 14.5×.
What does EV / sales mean?
Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.